Abbott Laboratories stock underperforms Thursday when compared to competitors
The stock's fall snapped a three-day winning streak.
Jim Cramer on Lawsuit Against Abbott Laboratories (ABT): ‘Dismiss It, Not Worry About It’
We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...
Hosted on MSN6h
Are Wall Street Analysts Bullish on Abbott Laboratories Stock?
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.
Abbott Laboratories stock outperforms competitors on strong trading day
Shares of Abbott Laboratories ABT rose 2.29% to $132.06 Wednesday, on what proved to be an all-around positive trading ...
StockStory.org on MSN7d
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 ...
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...